OLMASTRONI, ELENA
OLMASTRONI, ELENA
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry
2026 F. Galimberti, M.E. Capra, E. Olmastroni, D. Braghiroli, G. Banderali, F. Baratta, G. Biasucci, M. Biolo, P.S. Buonuomo, A.B. Cefalù, F. Cipollone, N. Citroni, S. D'Addato, S. Genovesi, O. Guardamagna, L. Iughetti, G. Mandraffino, I. Minicocci, G.G. Mombelli, T. Montalcini, F. Nascimbeni, A. Passaro, M. Pirro, E. Rinaldi, F. Sbrana, R. Scicali, P. Suppressa, P.J. Werba, M.G. Zenti, M. Arca, M. Averna, P. Tarugi, S. Calandra, A.L. Catapano, C. Pederiva, M. Casula, F. Abello, V. Bianconi, M. Brambilla, P. Bruzzi, A. Cicero, N. Cocomello, D. D'Ardes, L. D'Erasmo, B.D. Pino, G. Fainelli, Y. Ferro, E. Formisano, R. Franceschi, A. Giammanco, M. Giussani, S. Lugari, M. Lutterotti, S. Moriglia, S. Muntoni, C. Pavanello, C. Piras, S. Piro, L. Pisciotta, L. Rizzi, E. Sani, F. Spannella, A. Toscano, D. Vecchio, A. Zambon
Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study
2025 M. Casula, S. Scotti, F. Galimberti, G. Matteo Bruno, G. Lorenzo Colombo, A. Alieva, S. Xie, A.L. Catapano, E. Olmastroni
Lipoprotein(a) and prothrombotic effects: Evidence from a genetic association study
2025 E. Olmastroni, J.L. Katzmann, F. Galimberti, U. Laufs, A.L. Catapano
Enhancing Medication Adherence in Older Adults: A Systematic Review of Evidence‐Based Strategies
2025 S. Scotti, L. Pasina, C. Lunghi, E. Raschi, A. Rossi, E. Olmastroni, M. Salluzzo, S. Mucherino, V. Orlando, A. Nobili, E. Menditto, E. Poluzzi, M. Casula
Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trials
2025 S. Xie, F. Galimberti, E. Olmastroni, A.L. Catapano, M. Casula
Operational Definitions of Polypharmacy and Their Association with All-Cause Hospitalization Risk: A Conceptual Framework Using Administrative Databases
2025 S. Scotti, L. Scotti, F. Galimberti, S. Xie, M. Casula, E. Olmastroni
Contribution and interaction of polygenic predisposition and family history of coronary heart disease in predicting cardiovascular risk
2025 F. Galimberti, E. Olmastroni, M. Casula, S. Xie, A.L. Catapano
Attitudes and confidence toward deprescribing: a survey among Italian general practitioners
2025 A. Rossi, S. Scotti, L. Perrella, F. Galimberti, E. Olmastroni, E. Menditto, V. Orlando, I. Ardoino, C. Franchi, M. Casula
Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials
2024 S. Xie, F. Galimberti, E. Olmastroni, T.F. Luscher, S. Carugo, A.L. Catapano, M. Casula, C. Wanner, S. Yusuf, A. Maggioni, A. Kirby, H. Ogawa, E.K. Hoogeveen, I. Seljeflot, K. Welty, M. Benderly, J.E. Manson, K. Wolski, C.P. Cannon, F.J. Raal, D. Kallend, J. Foody, M. Louie
Plasma proteins associate with carotid plaques and predict incident atherosclerotic cardiovascular events
2024 A. Baragetti, L. Grigore, E. Olmastroni, E. Mattavelli, A. Catapano
Effect on C‐reactive protein levels of the addition of ezetimibe, bempedoic acid, or colchicine to statin treatment: A network meta‐analysis
2024 S. Xie, F. Galimberti, E. Olmastroni, A.L. Catapano, M. Casula
Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review
2024 A. Rossi, L. Perrella, S. Scotti, E. Olmastroni, F. Galimberti, I. Ardoino, V. Orlando, E. Menditto, C. Franchi, M. Casula
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries
2024 A. Alieva, A. Di Costanzo, M. Gazzotti, O. Reutova, E. Usova, V. Bakaleiko, M. Arca, L. D'Erasmo, F. Pellegatta, F. Galimberti, E. Olmastroni, A. Catapano, M. Casula
Longevity-associated BPIFB4 gene counteracts the inflammatory signaling.
2024 M. Cattaneo, A. Baragetti, A. Malovini, E. Ciaglia, V. Lopardo, E. Olmastroni, M. Casula, C. Ciacci, A. Catapano, A. Puca
A newly developed method for assessing co-exposure to free dose combinations: a proof-of-concept study using antihypertensive medications in Danish registers
2024 M. Antonietta Barbieri, S. Marie Neumann Nielsen, A. Rossi, E. Olmastroni, M. Casula, E. Spina, M. Sessa
Ezetimibe: Integrating Established Use with New Evidence - A Comprehensive Review
2024 E. Olmastroni, S. Scotti, F. Galimberti, S. Xie, M. Casula
Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review
2023 E. Olmastroni, F. Galimberti, E. Tragni, A.L. Catapano, M. Casula
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study
2023 M. Casula, M. Gazzotti, M.E. Capra, E. Olmastroni, F. Galimberti, A.L. Catapano, C. Pederiva
Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study
2023 E. Mattavelli, E. Olmastroni, M. Casula, L. Grigore, F. Pellegatta, A. Baragetti, P. Magni, A.L. Catapano
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network
2023 A. Catapano, L. Tokgözoğlu, M. Banach, M. Gazzotti, E. Olmastroni, M. Casula, K. Ray